Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 298

Работа: Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer

  1. Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy

    Junya Zhang, Yuxuan Hu, Xidan Wen +13

    Статья2025Цитирований: 2
    ABI
  2. The Cancer-Immunity Cycle in Multiple Myeloma

    Mika Casey, Kyohei Nakamura

    Обзорная статья2021Цитирований: 2
    ABI
  3. Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

    Gabriela Bindea, Bernhard Mlecnik, Marie Tosolini +14

    Статья2013Цитирований: 2
    ABI
  4. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

    Rumani Singh, Anthony Letai, Kristopher A. Sarosiek

    Обзорная статья2019Цитирований: 2
    ABI
  5. Cancer immunoediting: from immunosurveillance to tumor escape

    Gavin P. Dunn, Allen T. Bruce, Hiroaki Ikeda +2

    Обзорная статья2002Цитирований: 2
    ABI
  6. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy

    Seyedeh Alia Moosavian, Vanessa Bianconi, Matteo Pirro +1

    Обзорная статья2019Цитирований: 2
    ABI
  7. Nanomedicine-induced pyroptosis for anti-tumor immunotherapy: Mechanism analysis and application prospects

    Yuelin Huang, Chunting Wang, Yanhong Chen +2

    Обзорная статья2025Цитирований: 2
    ABI
  8. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

    Edward B. Garon, Naiyer A. Rizvi, Rina Hui +24

    Статья2015Цитирований: 2
    ABI
  9. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

    Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo +17

    Статья2018Цитирований: 2
    ABI
  10. The immune contexture in cancer prognosis and treatment

    Wolf H. Fridman, Laurence Zitvogel, Catherine Sautès‐Fridman +1

    Обзорная статья2017Цитирований: 2
    ABI
  11. Mitochondria as multifaceted regulators of cell death

    Florian J. Bock, Stephen W. G. Tait

    Обзорная статья2019Цитирований: 2
    ABI
  12. Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

    Matthew D. Hellmann, Luis Paz‐Ares, Reyes Bernabe Caro +23

    Статья2019Цитирований: 2
    ABI
  13. Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

    Jianjin Shi, Wenqing Gao, Feng Shao

    Обзорная статья2016Цитирований: 2
    ABI
  14. Cancer immunoediting and resistance to T cell-based immunotherapy

    Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth

    Обзорная статья2018Цитирований: 2
    ABI
  15. Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients

    Mao Lin, Haihua Luo, Shuzhen Liang +4

    Статья2020Цитирований: 2
    ABI
  16. Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy

    Nataša Avramović, Boris Mandić, Ana Savić-Radojević +1

    Обзорная статья2020Цитирований: 2
    ABI
  17. Tumor microenvironment complexity and therapeutic implications at a glance

    Roghayyeh Baghban, Leila Roshangar, Rana Jahanban‐Esfahlan +6

    Обзорная статья2020Цитирований: 2
    ABI